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ABSTRACT
In recent years, there have been prominent calls for a
new social contract that accords a more central role to
citizens in health research. Typically, this has been
understood as citizens and patients having a greater
voice and role within the standard research enterprise.
Beyond this, however, it is important that the
renegotiated contract speciﬁcally addresses the oversight
of a new, path-breaking approach to health research:
participant-led research. In light of the momentum
behind participant-led research and its potential to
advance health knowledge by challenging and
complementing traditional research, it is vital for all
stakeholders to work together in securing the conditions
that will enable it to ﬂourish.
It is increasingly commonplace to hear calls for
patients to have a greater voice in medicine and to
work in partnership with clinicians and researchers in
improving healthcare.1–3 In health research, funding
bodies and academic institutions actively undertake
patient and public involvement programmes to
ensure that studies adequately reﬂect the perspectives
and input of patients and citizens. Despite measures
to engage patients, however, their role still remains
limited within standard research. These limitations
have motivated a new approach to research in which
patients and citizens take matters into their own
hands in designing and conducting research activities.
We have termed this new phenomenon
participant-led research (PLR) and we contend that it
needs to be governed by a new social contract.
WHAT IS PLR?
As in standard research, PLR is an activity that
characteristically aims at the socially valued goal of
producing generalisable health knowledge.
However, it is distinctive in being initiated and con-
ducted by the participants themselves, often using
the tools of online social media. Many of the parti-
cipants in PLR are patients suffering from the con-
dition that is the subject of their research.
However, PLR also includes participants who are
not patients, but rather individuals interested in
acquiring health information, whether about them-
selves or more generally. The PLR label applies to a
very heterogeneous range of research activities.
Often, they cannot be sharply distinguished from
standard research, partly because of the tendency
of some PLR projects to evolve over time and
become entangled with standard research activity.4
Several examples illustrate the diversity of activ-
ity in the growing ﬁeld of PLR. Perhaps the most
well known case is the amyotrophic lateral sclerosis
(ALS) lithium study carried out on the online plat-
form PatientsLikeMe. It was initiated by two
patients with advanced-stage ALS from Brazil and
the USA, both of whom died prior to the comple-
tion of the study.5 One hundred and forty-nine
patients with ALS on the platform took lithium in
order to test the ﬁndings of a small earlier study
into its effects on disease progression and symptom
alleviation. The PatientsLikeMe ALS study, which
was completed over 8 months, was eventually pub-
lished in Nature Biotechnology. Its ﬁnding that
lithium had no effect was subsequently conﬁrmed
by standard clinical trials. 6
A rather different example, proﬁled recently in the
Wall Street Journal, is the research experiment con-
ducted by parents of children suffering from the
extremely rare lipid storage disease, Niemann-Pick
Type C.7 In their quest for a cure, the parents engaged
in extensive negotiations with the Food and Drug
Administration for permission to administer cyclodex-
trin to their children, ﬁrst intravenously, and then
eventually directly into the spinal ﬂuid. These activities
led to a phase 1 clinical trial of cyclodextrin.8 Other
examples of PLR activity include online platforms on
which individuals can upload their genetic data,
usually acquired via direct-to-consumer genomic com-
panies, for the purpose of initiating research.9 10
PLR activity is likely to become increasingly
common and diverse. Along with the call for greater
patient engagement in healthcare and participant-
centric initiatives for managing self-collected data,
various forms of PLR will aspire to become a recog-
nised part of the process of health knowledge produc-
tion. However, given the distinctive nature of these
activities, including their differences from standard
research, it is not obvious that they should be governed
by the existing social contract for health research. This
contract, which sets out norms and mechanisms for
conducting and recognising research, including over-
sight and accountability procedures, was devised
exclusively with standard research in mind. We there-
fore need to agree on a new social contract that will
enable us to harness the great potential of PLR while
avoiding the major pitfalls that lie in its path.
WHAT ARE THE POTENTIAL BENEFITS AND
PITFALLS?
PLR is potentially valuable as a source of generalis-
able health knowledge that beneﬁts participants
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and the wider society. Moreover, through PLR, this knowledge
can be generated in ways that realise the important value of par-
ticipation in scientiﬁc research, something to which there is a
human right under the broader rubric of participation in science
and culture.11 12 It promises to be a vital supplement to stand-
ard research: it can focus on conditions that are neglected by
standard research, such as rare diseases or side effects, and can
draw on a broader range of data and deliver outcomes more
rapidly.13 It can also be a way of realising valuable forms of
social interaction and support in cases where members of a com-
munity conduct PLR together, for example, patients suffering
from the same illness.
Like any mode of scientiﬁc research with human partici-
pants, however, PLR may involve the risk of harm to partici-
pants or others, including relatives. Beyond the issue of harm,
research activity may imperil societal values such as dignity and
justice. Certain characteristic features of PLR can exacerbate
these concerns: for example, self-experimentation may lead
participants to run excessive risks, and the existence of a com-
munity may provide a setting that facilitates undue peer pres-
sure and exploitation. In addition to these concerns, PLR may
face special obstacles in meeting epistemic standards required
of scientiﬁc research, including problems of bias and distortion
arising from the use of self-reported and self-collected
data.14 15
WHY IS A NEW SOCIAL CONTRACT NECESSARY?
It is important to negotiate the terms on which PLR is socially
recognised and enabled to ﬂourish, keeping the potential bene-
ﬁts and pitfalls in mind. Of course, society has a legitimate
general interest in regulating the permissibility of actions that
may harm those engaged in them or impact negatively on third
parties and publicly funded health services. However, our spe-
ciﬁc focus here is not on the permissibility of PLR. We assume
that PLR activity would be generally permissible within a just
legal framework. Instead, our focus is on the separate question
of the conditions under which PLR should be socially recog-
nised as a valuable means of contributing to generalisable health
knowledge. Such recognition carries with it further implications.
For example, it is a basis for providing material support for
PLR, incorporating its outputs into the body of scientiﬁc knowl-
edge and translating those outputs into practice.
The existing social contract does not explicitly recognise PLR
as an authentic mode of research, an omission that may have
various unwelcome consequences. For example, it could
undercut the motivation to engage in PLR activity, sending the
erroneous message that it is an eccentric and insigniﬁcant activ-
ity. It could also create obstacles to the dissemination and use of
generalisable knowledge acquired through PLR. For example,
journal editors may face the quandary of whether to publish
seemingly important research that has not gone through stand-
ard research oversight procedures, for example, ethics review by
a Research Ethics Committee (REC) or an Institutional Review
Board (IRB).
Clinicians may face similar problems, such as whether to
make use of PLR ﬁndings, even if they have been published, or
how best to advise patients who are contemplating the prospect
of engaging in such research. More generally, PLR will present
health practitioners with patients who have a novel proﬁle. In
addition to having scientiﬁc understanding of their condition,
they will also have the experience of taking responsibility for
research design, oversight and implementation. This enhanced
status is likely to have transformative implications for the
patient-practitioner relationship.16
In light of this situation, we propose that the new social con-
tract on health research should set out relevant standards that
those involved in PLR must satisfy if their activities are to be
socially recognised as research. In turn, the wider society,
including scientiﬁc journals, funding bodies and healthcare pro-
fessionals, would have corresponding responsibilities to recog-
nise and facilitate PLR that meets these standards.
SOCIAL RECOGNITION OF PLR AS RESEARCH: A MATTER
OF MUTUAL RESPONSIBILITY
The rationale for subjecting health research to oversight, scien-
tiﬁc and ethical, is to facilitate its ability to produce generalis-
able health knowledge that can be properly recognised and used
by the participants and society. Such oversight provides assur-
ance of the scientiﬁc quality of research outcomes, and the
ethical acceptability of the ways in which they were achieved.
The same quality assurance requirements apply in no less
measure to PLR if it is to be recognised as genuine research.
In standard research the means of securing these requirements
involve formal scientiﬁc and ethical review. In relation to PLR,
by contrast, such mechanisms tend to be neither in operation,
nor easily accessible. A crucial question is whether PLR should
also be subjected to identical formal oversight mechanisms. The
worry is that these mechanisms may needlessly deter or burden
those engaged in valuable forms of PLR due to the cost, delay
and difﬁculty of undergoing formal review.
To strengthen the ability of PLR to meet the conditions for
social recognition, we should be prepared to accept alternative
mechanisms of oversight that are adapted to the distinctive char-
acter of PLR.17 Appropriate mechanisms should be identiﬁed in
a new social contract on PLR that outlines the reciprocal respon-
sibilities of those engaged in PLR activities and of others in the
societies hosting these activities. The social contract would
facilitate PLR activity by providing a publicly accessible set of
standards for its oversight, operating as a focal point that coor-
dinates the activities of diverse stakeholders in relation to such
research, for example, PLR practitioners, journal editors,
funding bodies, health professionals, regulators, etc.
CONSTRUCTING THE TERMS OF THE NEW SOCIAL
CONTRACT
In shaping the terms of the new social contract that enables PLR
to be recognised as a legitimate, reliable and responsible
research activity, the points listed below should be taken into
account. These considerations are offered, in the ﬁrst instance,
as governing the ‘soft regulation’ of PLR, by means of socially
acknowledged responsibilities, rather than legally enforceable
measures. It follows that an effective social contract will require
a real sense of ownership on the part of relevant stakeholders,
especially those engaged in PLR activities. This includes their
full participation in the negotiation of the new social contract.
1. Uniform ethical and scientiﬁc standards apply throughout.
PLR should meet the same high ethical and scientiﬁc stan-
dards expected of standard research. PLR should not be rele-
gated per se to the status of ‘second-class’ research, either
ethically or scientiﬁcally. Equally, however, standards should
not be relaxed to allow poor quality research to be passed
off as ﬁrst-class research. 18
2. Uniform standards may be secured through diverse mechan-
isms of oversight. Although ethical and scientiﬁc standards
apply uniformly across all types of research, the most appro-
priate means for securing them may vary from one kind of
research to another. We should not assume that a
one-size-ﬁts-all mechanism of oversight is best. Instead, we
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must explore various approaches which take into account
the distinctive nature of the research in question. Moreover,
given the heterogeneous character of PLR activity, different
oversight mechanisms may apply to different kinds of
research within that general category.17
3. Features of PLR which might justify alternative mechanisms
of oversight. Among the various ways in which PLR tends to
contrast with standard research are the following: PLR is
usually pursued outside of institutional frameworks and
without ofﬁcial endorsement or support; it is often a less
formally structured peer-to-peer activity, but not one in
which power relations among participants are absent; parti-
cipants often have a direct health interest in the outcome of
research; the research conducted may address issues outside
of the scientiﬁc mainstream, or may challenge mainstream
approaches; the research is often not motivated by commer-
cial proﬁt or career advancement; it is more likely to involve
forms of self-experimentation; it may be conducted in a
more ‘open’ or ‘transparent’ manner, especially when
enabled by online media; and so on. These and other differ-
entiating features do not have uniform implications for the
oversight of PLR, and such implications need to be balanced
in devising suitable oversight mechanisms.19
4. Procedural and substantive dimensions of oversight. In adapt-
ing oversight mechanisms to the distinctive nature of PLR,
we should distinguish their procedural and substantive
dimensions. Procedural questions concern the means
through which oversight is to be achieved, for example,
through traditional REC or IRB, a committee of participants,
crowd-sourcing, etc. Substantive questions concern the con-
siderations that those operating the procedures should bring
to bear in judging the acceptability of a research proposal.
5. Procedural adaptation. We should not simply assume that
the procedure through which oversight is conducted must
involve standard research ethics review (REC/IRB). The
automatic and wholesale imposition of this mode of review,
with its ﬁnancial burdens and delay, threatens to discourage
or stiﬂe valuable forms of PLR activity. Instead, it is impera-
tive to explore other procedures of oversight, and also to
entertain the possibility that different procedures are applic-
able to different kinds of activity within the PLR rubric.
Among the alternatives worth exploring in this way is ethical
oversight by means of crowd-sourcing or swarm-sourcing
(a more ﬁltered version of the former).
6. Substantive adaptation. Even though the ultimate standards
of oversight are uniform across all forms of research, certain
considerations may assume a special prominence in PLR.
While risk to participants remains the primary ethical
concern, PLR’s distinctive nature may demand a special
focus on matters such as the interests of third parties (includ-
ing children of participants involved in research) or wider
societal values, data protection concerns arising out of the
extensive use of online media, and the corrosion of
informed consent through peer pressure and group dynam-
ics, among others.20
7. Responsibilities on participants and society. Practitioners of
PLR have a responsibility to meet relevant ethical and scientiﬁc
standards as a condition of their research being socially recog-
nised. Correspondingly, society has an obligation to enable par-
ticipants in PLR to discharge their responsibilities, and a
further obligation to accord PLR its due recognition as research
when the relevant ethical and scientiﬁc standards are met.
8. Forms of social facilitation of PLR. It is necessary to investi-
gate ways in which society might appropriately discharge its
obligation to facilitate valuable PLR activities. Some possibil-
ities worth exploring include: the development of an online
platform where PLR activities may be publicly registered; the
provision of scientiﬁc advice on research proposals through
publicly funded panels of experts, operating at an inter-
national level; online tools, including scientiﬁc and ethical
checklists of relevant considerations; and, the development of
journal appraisal systems that are known to be receptive to
submissions of results from PLR. Those engaged in PLR,
along with other stakeholders, should contribute to an
ongoing dialogue about possible means of social facilitation.
NEXT STEPS: A RESEARCH AGENDA
The potential beneﬁts and pitfalls of PLR demand further inter-
disciplinary inquiry. A vital starting point will be empirical inves-
tigations to map the various forms of existing PLR activity, their
prevalence and distribution; to understand the objectives of
those engaged in it; to explore their experiences, including how
they address the ethical challenges; and to identify their per-
spectives on how PLR may best be facilitated. On the basis of
these empirical ﬁndings, further research activity should be con-
ducted on normative questions surrounding PLR. These ques-
tions include the bearing of existing legal and institutional
norms, and how they might be revised or supplemented in
order to foster PLR activity. More fundamentally, they also
include the underlying values that PLR activity serves, such as
the individual right to scientiﬁc and cultural participation and
the common good of a more participatory scientiﬁc culture.
In forging the new social contract on health research, we
need seriously to consider the scope and content of its terms.
Key among those terms must be a set of mutual responsibilities
that facilitates the realisation of PLR’s full potential as an
innovative form of research in which we are all stakeholders.
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